Nanogen, Prodesse link for disease diagnostics

Sept. 12, 2003 — Nanogen Inc. and Prodesse Inc. are developing microarray-based products to detect infectious diseases such as influenza, pneumonia, West Nile Virus and SARS, according to a news release.

The companies will integrate Milwaukee-based Prodesse’s multiplex amplification technology with San Diego-based Nanogen’s NanoChip Molecular Biology Workstation. The firms expect to produce a process for testing patient samples within hours, enabling physicians to obtain results and prescribe drugs.

Such an approach could help reduce overuse of antibiotics, which has increased antibiotic-resistant strains of bacteria and decreased effectiveness of many antibiotics, the release said.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.